ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
17612 Ergebnisse für "tolerated s" unter ETH Zürich - Numerische Materialmodellierung
Player Simulation and General Adversary Structures in Perfect Multi...
... passive model, any adversary that corrupts less than $n/2$ players can be tolerated, and in the active ... model, any adversary that corrupts less than $n/3$ players can be tolerated. Strictly generalizing these ... S ... that corrupts less than $n/2$ players can be tolerated, and in the active model, any adversary that ... S ...
Complete Characterization of Adversaries Tolerable in Secure Multi-...
... state that less than $n/2$ passive or less than $n/3$ active adversaries can be tolerated; assuming a ... S ... less than $n/2$ passive or less than $n/3$ active adversaries can be tolerated; assuming a broadcast ... S ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
7497 Ergebnisse für "tolerated s" unter Somagenetix
Benralizumab in Eosinophilic Granulomatosis with Polyangiitis compl...
... as primarily infective. Active EGPA with cardiac and CNS involvement complicated by a secondary S ... therapy was combined with Benralizumab, which was well tolerated and EGPA resolved rapidly. Benralizumab ... s ... infective. Active EGPA with cardiac and CNS involvement complicated by a secondary S. aureus sepsis was ... s ...
The effect of S-adenosylmethionine on self-mutilation in a patient ...
... effect of S-adenosylmethionine (SAM) on the neurological symptoms, which motivated us to evaluate this ... tolerated, a total of 1,762 events of self-mutilation were recorded, of which 1,281 events were in the ... The effect of S-adenosylmethionine on self-mutilation in a patient with Lesch-Nyhan disease ... The effect of S-adenosylmethionine on self-mutilation in a patient with Lesch-Nyhan disease ... The effect of S-adenosylmethionine on self-mutilation in a patient with Lesch-Nyhan disease ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
4792 Ergebnisse für "tolerated s" unter University of Zurich
Correction of metabolic acidosis with potassium citrate in renal tr...
... transplant patients with metabolic acidosis ( S-[HCO(3)(-)] <24 mmol/L) undergoing treatment with either ... potassium citrate to maintain S-[HCO(3)(-)] >24 mmol/L, or potassium chloride (control group). Iliac crest ... included 30 renal transplant patients with metabolic acidosis ( S-[HCO(3)(-)] <24 mmol/L) undergoing ... treatment with either potassium citrate to maintain S-[HCO(3)(-)] >24 mmol/L, or potassium chloride (control ...
Successful treatment of SAPHO syndrome with apremilast - Zurich Ope...
... improve symptoms. Therapy with etanercept was not tolerated, and due to a previous demyelinating ... tolerated, and due to a previous demyelinating peripheral neuropathy, further treatment with TNF inhibitors ... syndrome with apremilast Adamo, S ; Nilsson, J ; Krebs, A ; Steiner, U ; Cozzio, A ; French, L E ; Kolios ... tolerated, and due to a previous demyelinating peripheral neuropathy, further treatment with TNF inhibitors ...
ETH Zürich - Feasibility Lab
Technoparkstrasse 1
8005 Zürich
14750 Ergebnisse für "tolerated s" unter ETH Zürich - Feasibility Lab
... Distributed Computing HS 2010 B. Keller / M. Kuhn / S. Welten / Prof. R. Wattenhofer Distributed ... possible to achieve a quorum anymore and the quorum system does not work anymore. 3 S-Uniform Quorum ... Distributed Computing HS 2010 B. Keller / M. Kuhn / S. Welten / Prof. R. Wattenhofer Distributed ... possible to achieve a quorum anymore and the quorum system does not work anymore. 3 S-Uniform Quorum ...
... S uses the code word s ∈ C to send a 1 and s¯ to send a 0. The other stations Si 6= S use other code ... words si ∈ C and the respective complements s¯i to send their bits. Additionally we add a random noise ... S uses the code word s ∈ C to send a 1 and s¯ to send a 0. The other stations Si 6= S use other code ... words si ∈ C and the respective complements s¯i to send their bits. Additionally we add a random noise ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
74 Ergebnisse für "tolerated s" unter CSL Vifor
News Releases | CSL
... through 108 weeks of treatment Sparsentan was well- tolerated with a consistent safety profile across all ... - tolerated and has shown a comparable safety profile to irbesartan. "This is a preliminary data picture from ... emissions by 2030. Learn About Our Targets Along with our sustainability strategy, CSL’ s community ... proteinuria that was sustained through 108 weeks of treatment Sparsentan was well- tolerated with a consistent ...
News Releases | CSL
... , randomized multicenter study showed that Ferinject® is an effective and well- tolerated alternative to iron ... . Last accessed: June 2018. Hercberg S, et al. Iron deficiency in Europe. Public Health Nutr. 2007;4(2b ... emissions by 2030. Learn About Our Targets Along with our sustainability strategy, CSL’ s community ... an effective and well- tolerated alternative to iron sucrose for the treatment of iron deficiency ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
4493 Ergebnisse für "tolerated s" unter ETH Entrepreneurship
S: j_jnNORPIEProceeding_indledning.PDF
... S: j_jnNORPIEProceeding_indledning.PDF A Novel Concept for Transformer Volt Second Balancing of a ... D − − = (2) uΔ K(z) GH0 uT,1 + im,m + - i =0m,ref T T +uΔ TTD Sensor 1+sT1 1 sT 1 Reset sLH 1 S/H S ... S: j_jnNORPIEProceeding_indledning.PDF ... S: j_jnNORPIEProceeding_indledning.PDF A Novel Concept for Transformer Volt Second Balancing of a ... S: j_jnNORPIEProceeding_indledning.PDF ...
A/S website
... Welcome to the A/ S Research Group The Chair of Architecture and Building Systems (A/ S) is an ... Gebäudesysteme (A/ S) ist ein interdisziplinäres Forscherteam, das aktive und passive Systeme der ... A/ S website ... A/ S website 0 Skip to Content Team – view all – Arno Schlueter Marco Baur Krishna Bharathi Esther ... A/ S website ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
773 Ergebnisse für "tolerated s" unter University Hospital Zurich, Research and Education Office
... - tolerated treatment strategies for these diseases. OVERVIEW In our clinic, we treat women that have ... adenocarcinoma. Anugraham M, Jacob F, Everest-Dass AV, Schoetzau A, Nixdorf S, Hacker NF, Fink D, Heinzelmann ... - tolerated treatment strategies for these diseases. OVERVIEW In our clinic, we treat women that have ... adenocarcinoma. Anugraham M, Jacob F, Everest-Dass AV, Schoetzau A, Nixdorf S, Hacker NF, Fink D, Heinzelmann ...
... to explore how such insights can be translated towards more effective and better- tolerated anti ... SE, Shorrocks AK, de Marco Zompit M, Day M, Blaauwendraad J, Bundschuh D, Bonham S, Fischer R, Fink D ... to explore how such insights can be translated towards more effective and better- tolerated anti ... SE, Shorrocks AK, de Marco Zompit M, Day M, Blaauwendraad J, Bundschuh D, Bonham S, Fischer R, Fink D ...
KYON AG
Hardturmstrasse 103
8005 Zürich
41 Ergebnisse für "tolerated s" unter KYON AG
Dog Hip Arthritis | THR Surgery | THR Surgery Cost
... tolerated the surgery very well and we thought her recovery was remarkably fast. Within a day, she was in ... control cookies, see here: Cookie Policy  I N V E N T • D E S I G N • D E V E ... , then later for her left hip. Lacey tolerated the surgery very well and we thought her recovery was ... control cookies, see here: Cookie Policy  I N V E N T • D E S I G N • D E V E L O P ...
Stainless Steel or Titanium? This is why our products are made from...
... implant is, the more it will be tolerated by the body. That means a lower risk of infection and higher ... be tolerated by the body. That means a lower risk of infection and higher chances for good healing ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
46 Ergebnisse für "tolerated s" unter Bio-Technopark Schlieren-Zürich
Molecular Partners Provides Update from ACTIV-3 Global Clinical Stu...
... randomized in the ensovibep arm of the study. Ensovibep was observed to be generally safe and well tolerated ... ’ infectious disease pipeline. As a DARPin therapeutic candidate, it is designed to target SARS-CoV-2’ s spike ... observed to be generally safe and well tolerated with reported side effects consistent with standard of ... candidate, it is designed to target SARS-CoV-2’ s spike protein at three sites to limit viral escape via ...
Interim Management Statement Q1 2023 of Molecular Partners: Well Ca...
... localized CD40 activation provided by MP0317. The candidate was also seen to be safe and well tolerated ... . Humanized mouse models confirmed MP0533’ s ability to activate intra-tumoral T-cells and control tumor growth ... CD40 activation provided by MP0317. The candidate was also seen to be safe and well tolerated. MP0317 ... . Humanized mouse models confirmed MP0533’ s ability to activate intra-tumoral T-cells and control tumor growth ...
